CAS 262352-17-0 MFCD08063631-TORCETRAPIB-D3 -LabNovo

SMILES: [2H]C([2H])([2H])OC(=O)N(CC1C=C(C=C(C=1)C(F)(F)F)C(F)(F)F)[C@H]1C[C@@H](CC)N(C(=O)OCC)C2C=CC(=CC=21)C(F)(F)F

Mol. Formula	C26H22D3F9N2O4
Mol. Weight	603.494

Chemical Name	TORCETRAPIB-D3
Chemical Name Translation

信息真实价格透明资金保障专业采购外包团队在线服务

品牌质保精细包装现货库存一流品牌服务

[2]. Hu X, et al. Torcetrapib induces aldosterone and cortisol production by an intracellular calcium-mediated mechanism independently of cholesteryl ester transfer protein inhibition. Endocrinology. 2009 May;150(5):2211-9.
[3]. Barter PJ, et al. Effects of torcetrapib in patients at high risk for coronary events. N Engl J Med. 2007 Nov 22;357(21):2109-22.
[4]. Morehouse LA, et al. Inhibition of CETP activity by torcetrapib reduces susceptibility to diet-induced atherosclerosis in New Zealand White rabbits. J Lipid Res. 2007 Jun;48(6):1263-72.
[1]. Clark RW, et al. Raising high-density lipoprotein in humans through inhibition of cholesteryl ester transfer protein: an initial multidose study of torcetrapib. Arterioscler Thromb V
[1]. Clark RW, et al. Raising high-density lipoprotein in humans through inhibition of cholesteryl ester transfer protein: an initial multidose study of torcetrapib. Arterioscler Thromb Vasc Biol. 2004 Mar;24(3):490-7.

相关产品推荐